M J Bogusz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 3,4-Methylenedioxyamphetamine/adverse effects3,4-Methylenedioxyamphetamine/analogs & derivatives3,4-Methylenedioxyamphetamine/antagonists & inhibitorsAcute DiseaseDesigner Drugs/adverse effectsHeroin/adverse effectsHeroin/antagonists & inhibitorsHumansNarcotic Antagonists/pharmacologyNarcotics/adverse effectsSubstance-Related Disorders
Substances: See more » Designer DrugsNarcotic AntagonistsNarcotics3,4-MethylenedioxyamphetamineHeroin3,4-methylenedioxyethamphetamine
Year: 1998 PMID: 9539085 DOI: 10.1007/s001340050547
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440